Remove 2025 Remove Epilepsy Remove THC Remove Topical
article thumbnail

New York Medical Marijuana Guide

Cannabis Law Report

The Department of Health conducted a formal study on this topic in 2018. Researchers predict that the market will be valued at $7 billion by the year 2025. State residents can purchase cannabis-based products with THC content above 0.3% of THC are available to the public without a medical certification.

article thumbnail

Article: Who is Impacted if Marijuana is Reclassified as a Schedule II Drug

Cannabis Law Report

She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases. billion in federal tax revenue between 2017 and 2025. That is another topic to be explored. [i] i] [link]. [ii]

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is CBD safe? FDA Issues Warning Letters to Companies

Puff Puff Post

The FDA’s Consumer Update reiterated that, with the exception of Epidiolex (a CBD drug for rare forms of epilepsy), the FDA hasn’t approved any other forms of CBD. billion, and is expected to grow dramatically by 2025. The bottom line is that cannabis-infused products (both THC and CBD) are big business.

CBD 52
article thumbnail

Meritas Law Firms Worldwide Article: Global Cannabis Industry: The Essential Primer

Cannabis Law Report

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. Not only are makers of foods, health and beauty products, and supplements interested in CBD and THC.

Law 40